Expressing support for the designation of July 16, 2025, as "Glioblastoma Awareness Day".

Glioblastoma is the most aggressive and deadly type of brain tumor, with a median survival of just 8 months and a five-year survival rate of only 6.9 percent. An estimated 13,000 Americans will be diagnosed with it in 2025, and over 10,000 will die from it. Despite first being described in medical literature over 100 years ago, only 5 drugs and 1 medical device have ever been approved specifically to treat it, and mortality rates have barely changed in 30 years. This resolution supports designating July 16, 2025, as Glioblastoma Awareness Day and calls for continued investment in research, including through the National Cancer Institute's Glioblastoma Therapeutics Network.